[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Meningococcal Conjugate Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 117 pages | ID: G8C56DBDADBGEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

SCOPE OF THE REPORT:

This report studies the Meningococcal Conjugate market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Meningococcal Conjugate market by product type and applications/end industries.
The global Meningococcal Conjugate market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Meningococcal Conjugate.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
  • Sanofi Pasteur
  • Pfizer
  • Glaxo Smith Kline
  • Hualan Biological Engineering
  • JN International Medical Corporation
  • Baxter International
  • Merck
  • Serum Institute of India
  • Biomed
  • Novartis
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Menactra
  • Menveo
  • NeisVac-C
  • Nimenrix
  • Others
Market Segment by Applications, can be divided into
  • Children
  • Preteens or Teens
  • Adults
1 MENINGOCOCCAL CONJUGATE MARKET OVERVIEW

1.1 Product Overview and Scope of Meningococcal Conjugate
1.2 Classification of Meningococcal Conjugate by Types
  1.2.1 Global Meningococcal Conjugate Revenue Comparison by Types (2017-2023)
  1.2.2 Global Meningococcal Conjugate Revenue Market Share by Types in 2017
  1.2.3 Menactra
  1.2.4 Menveo
  1.2.5 NeisVac-C
  1.2.6 Nimenrix
  1.2.7 Others
1.3 Global Meningococcal Conjugate Market by Application
  1.3.1 Global Meningococcal Conjugate Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Children
  1.3.3 Preteens or Teens
  1.3.4 Adults
1.4 Global Meningococcal Conjugate Market by Regions
  1.4.1 Global Meningococcal Conjugate Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Meningococcal Conjugate Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Meningococcal Conjugate Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Meningococcal Conjugate Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Meningococcal Conjugate Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Meningococcal Conjugate Status and Prospect (2013-2023)
1.5 Global Market Size of Meningococcal Conjugate (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Sanofi Pasteur
  2.1.1 Business Overview
  2.1.2 Meningococcal Conjugate Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Sanofi Pasteur Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
  2.2.1 Business Overview
  2.2.2 Meningococcal Conjugate Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Pfizer Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
2.3 Glaxo Smith Kline
  2.3.1 Business Overview
  2.3.2 Meningococcal Conjugate Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Glaxo Smith Kline Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
2.4 Hualan Biological Engineering
  2.4.1 Business Overview
  2.4.2 Meningococcal Conjugate Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Hualan Biological Engineering Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
2.5 JN International Medical Corporation
  2.5.1 Business Overview
  2.5.2 Meningococcal Conjugate Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 JN International Medical Corporation Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
2.6 Baxter International
  2.6.1 Business Overview
  2.6.2 Meningococcal Conjugate Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Baxter International Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
  2.7.1 Business Overview
  2.7.2 Meningococcal Conjugate Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Merck Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
2.8 Serum Institute of India
  2.8.1 Business Overview
  2.8.2 Meningococcal Conjugate Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Serum Institute of India Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
2.9 Biomed
  2.9.1 Business Overview
  2.9.2 Meningococcal Conjugate Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Biomed Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis
  2.10.1 Business Overview
  2.10.2 Meningococcal Conjugate Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Novartis Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL MENINGOCOCCAL CONJUGATE MARKET COMPETITION, BY PLAYERS

3.1 Global Meningococcal Conjugate Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Meningococcal Conjugate Players Market Share
  3.2.2 Top 10 Meningococcal Conjugate Players Market Share
3.3 Market Competition Trend

4 GLOBAL MENINGOCOCCAL CONJUGATE MARKET SIZE BY REGIONS

4.1 Global Meningococcal Conjugate Revenue and Market Share by Regions
4.2 North America Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
4.3 Europe Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
4.5 South America Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Meningococcal Conjugate Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA MENINGOCOCCAL CONJUGATE REVENUE BY COUNTRIES

5.1 North America Meningococcal Conjugate Revenue by Countries (2013-2018)
5.2 USA Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
5.3 Canada Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
5.4 Mexico Meningococcal Conjugate Revenue and Growth Rate (2013-2018)

6 EUROPE MENINGOCOCCAL CONJUGATE REVENUE BY COUNTRIES

6.1 Europe Meningococcal Conjugate Revenue by Countries (2013-2018)
6.2 Germany Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
6.3 UK Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
6.4 France Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
6.5 Russia Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
6.6 Italy Meningococcal Conjugate Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC MENINGOCOCCAL CONJUGATE REVENUE BY COUNTRIES

7.1 Asia-Pacific Meningococcal Conjugate Revenue by Countries (2013-2018)
7.2 China Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
7.3 Japan Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
7.4 Korea Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
7.5 India Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Meningococcal Conjugate Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA MENINGOCOCCAL CONJUGATE REVENUE BY COUNTRIES

8.1 South America Meningococcal Conjugate Revenue by Countries (2013-2018)
8.2 Brazil Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
8.3 Argentina Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
8.4 Colombia Meningococcal Conjugate Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE MENINGOCOCCAL CONJUGATE BY COUNTRIES

9.1 Middle East and Africa Meningococcal Conjugate Revenue by Countries (2013-2018)
9.2 Saudi Arabia Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
9.3 UAE Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
9.4 Egypt Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
9.5 Nigeria Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
9.6 South Africa Meningococcal Conjugate Revenue and Growth Rate (2013-2018)

10 GLOBAL MENINGOCOCCAL CONJUGATE MARKET SEGMENT BY TYPE

10.1 Global Meningococcal Conjugate Revenue and Market Share by Type (2013-2018)
10.2 Global Meningococcal Conjugate Market Forecast by Type (2018-2023)
10.3 Menactra Revenue Growth Rate (2013-2023)
10.4 Menveo Revenue Growth Rate (2013-2023)
10.5 NeisVac-C Revenue Growth Rate (2013-2023)
10.6 Nimenrix Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)

11 GLOBAL MENINGOCOCCAL CONJUGATE MARKET SEGMENT BY APPLICATION

11.1 Global Meningococcal Conjugate Revenue Market Share by Application (2013-2018)
11.2 Meningococcal Conjugate Market Forecast by Application (2018-2023)
11.3 Children Revenue Growth (2013-2018)
11.4 Preteens or Teens Revenue Growth (2013-2018)
11.5 Adults Revenue Growth (2013-2018)

12 GLOBAL MENINGOCOCCAL CONJUGATE MARKET SIZE FORECAST (2018-2023)

12.1 Global Meningococcal Conjugate Market Size Forecast (2018-2023)
12.2 Global Meningococcal Conjugate Market Forecast by Regions (2018-2023)
12.3 North America Meningococcal Conjugate Revenue Market Forecast (2018-2023)
12.4 Europe Meningococcal Conjugate Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Meningococcal Conjugate Revenue Market Forecast (2018-2023)
12.6 South America Meningococcal Conjugate Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Meningococcal Conjugate Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source



LIST OF TABLES AND FIGURES

Figure Meningococcal Conjugate Picture
Table Product Specifications of Meningococcal Conjugate
Table Global Meningococcal Conjugate and Revenue (Million USD) Market Split by Product Type
Figure Global Meningococcal Conjugate Revenue Market Share by Types in 2017
Figure Menactra Picture
Figure Menveo Picture
Figure NeisVac-C Picture
Figure Nimenrix Picture
Figure Others Picture
Table Global Meningococcal Conjugate Revenue (Million USD) by Application (2013-2023)
Figure Meningococcal Conjugate Revenue Market Share by Applications in 2017
Figure Children Picture
Figure Preteens or Teens Picture
Figure Adults Picture
Table Global Market Meningococcal Conjugate Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Meningococcal Conjugate Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Meningococcal Conjugate Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Meningococcal Conjugate Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Meningococcal Conjugate Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Meningococcal Conjugate Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Meningococcal Conjugate Revenue (Million USD) and Growth Rate (2013-2023)
Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table Sanofi Pasteur Meningococcal Conjugate Type and Applications
Table Sanofi Pasteur Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Meningococcal Conjugate Type and Applications
Table Pfizer Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table Glaxo Smith Kline Basic Information, Manufacturing Base and Competitors
Table Glaxo Smith Kline Meningococcal Conjugate Type and Applications
Table Glaxo Smith Kline Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table Hualan Biological Engineering Meningococcal Conjugate Type and Applications
Table Hualan Biological Engineering Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table JN International Medical Corporation Basic Information, Manufacturing Base and Competitors
Table JN International Medical Corporation Meningococcal Conjugate Type and Applications
Table JN International Medical Corporation Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table Baxter International Basic Information, Manufacturing Base and Competitors
Table Baxter International Meningococcal Conjugate Type and Applications
Table Baxter International Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Meningococcal Conjugate Type and Applications
Table Merck Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table Serum Institute of India Meningococcal Conjugate Type and Applications
Table Serum Institute of India Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table Biomed Basic Information, Manufacturing Base and Competitors
Table Biomed Meningococcal Conjugate Type and Applications
Table Biomed Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Meningococcal Conjugate Type and Applications
Table Novartis Meningococcal Conjugate Revenue, Gross Margin and Market Share (2016-2017)
Table Global Meningococcal Conjugate Revenue (Million USD) by Players (2013-2018)
Table Global Meningococcal Conjugate Revenue Share by Players (2013-2018)
Figure Global Meningococcal Conjugate Revenue Share by Players in 2016
Figure Global Meningococcal Conjugate Revenue Share by Players in 2017
Figure Global Top 5 Players Meningococcal Conjugate Revenue Market Share in 2017
Figure Global Top 10 Players Meningococcal Conjugate Revenue Market Share in 2017
Figure Global Meningococcal Conjugate Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Meningococcal Conjugate Revenue (Million USD) by Regions (2013-2018)
Table Global Meningococcal Conjugate Revenue Market Share by Regions (2013-2018)
Figure Global Meningococcal Conjugate Revenue Market Share by Regions (2013-2018)
Figure Global Meningococcal Conjugate Revenue Market Share by Regions in 2017
Figure North America Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Europe Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure South America Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Table North America Meningococcal Conjugate Revenue by Countries (2013-2018)
Table North America Meningococcal Conjugate Revenue Market Share by Countries (2013-2018)
Figure North America Meningococcal Conjugate Revenue Market Share by Countries (2013-2018)
Figure North America Meningococcal Conjugate Revenue Market Share by Countries in 2017
Figure USA Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Canada Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Mexico Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Table Europe Meningococcal Conjugate Revenue (Million USD) by Countries (2013-2018)
Figure Europe Meningococcal Conjugate Revenue Market Share by Countries (2013-2018)
Figure Europe Meningococcal Conjugate Revenue Market Share by Countries in 2017
Figure Germany Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure UK Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure France Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Russia Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Italy Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Meningococcal Conjugate Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Meningococcal Conjugate Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Meningococcal Conjugate Revenue Market Share by Countries in 2017
Figure China Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Japan Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Korea Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure India Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Table South America Meningococcal Conjugate Revenue by Countries (2013-2018)
Table South America Meningococcal Conjugate Revenue Market Share by Countries (2013-2018)
Figure South America Meningococcal Conjugate Revenue Market Share by Countries (2013-2018)
Figure South America Meningococcal Conjugate Revenue Market Share by Countries in 2017
Figure Brazil Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Argentina Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Colombia Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Meningococcal Conjugate Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Meningococcal Conjugate Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Meningococcal Conjugate Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Meningococcal Conjugate Revenue Market Share by Countries in 2017
Figure Saudi Arabia Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure UAE Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Egypt Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure Nigeria Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Figure South Africa Meningococcal Conjugate Revenue and Growth Rate (2013-2018)
Table Global Meningococcal Conjugate Revenue (Million USD) by Type (2013-2018)
Table Global Meningococcal Conjugate Revenue Share by Type (2013-2018)
Figure Global Meningococcal Conjugate Revenue Share by Type (2013-2018)
Figure Global Meningococcal Conjugate Revenue Share by Type in 2017
Table Global Meningococcal Conjugate Revenue Forecast by Type (2018-2023)
Figure Global Meningococcal Conjugate Market Share Forecast by Type (2018-2023)
Figure Global Menactra Revenue Growth Rate (2013-2018)
Figure Global Menveo Revenue Growth Rate (2013-2018)
Figure Global NeisVac-C Revenue Growth Rate (2013-2018)
Figure Global Nimenrix Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Meningococcal Conjugate Revenue by Application (2013-2018)
Table Global Meningococcal Conjugate Revenue Share by Application (2013-2018)
Figure Global Meningococcal Conjugate Revenue Share by Application (2013-2018)
Figure Global Meningococcal Conjugate Revenue Share by Application in 2017
Table Global Meningococcal Conjugate Revenue Forecast by Application (2018-2023)
Figure Global Meningococcal Conjugate Market Share Forecast by Application (2018-2023)
Figure Global Children Revenue Growth Rate (2013-2018)
Figure Global Preteens or Teens Revenue Growth Rate (2013-2018)
Figure Global Adults Revenue Growth Rate (2013-2018)
Figure Global Meningococcal Conjugate Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Meningococcal Conjugate Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Meningococcal Conjugate Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Meningococcal Conjugate Revenue Market Forecast (2018-2023)
Figure Europe Meningococcal Conjugate Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Meningococcal Conjugate Revenue Market Forecast (2018-2023)
Figure South America Meningococcal Conjugate Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Meningococcal Conjugate Revenue Market Forecast (2018-2023)


More Publications